Gossamer Bio Other Long Term Assets (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.74 +0.14 (+5.38%) USD | NASDAQ | Jan 21, 16:00

2.83 +0.09 (+3.28%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	Upgrade
Rezolute, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade